The Commission shall adopt delegated acts in accordance with Article 21 of this Regulation. The Commission shall adopt delegated acts in accordance with Article 21 of this Regulation

The Commission shall adopt delegated acts in accordance with Article 21 of this Regulation. The Commission shall adopt delegated acts in accordance with Article 21 of this Regulation.
HUS has an agreement with Agilent Technologies Finland Oy for the purchase of automated immunosuppressants.The agreement entered into force on 8 May 2019 and the current contract period ends on 31 October 2026.The contract decision based on the new procurement of HUS automated immune immunosupppressants (HUS 424-2025) has been adopted and the contract for the use of the contract has been signed.The new installation is underway.As the new installation progresses, it has become clear that verification for the new installations cannot be carried out in accordance with the original timetable by the end of the current contractual period.1.11.2026 - 31.12.2026 Continuation of the current agreement is essential to ensure that diagnostic activities are maintained during the transition period and that the new terminal can be operated in a safe and orderly manner.